Direct-to-Patient and Virtual Clinical Trials is the ideal platform to talk about how the impact of this crisis has created a new normal with decentralised trials creating benefits including enabling more patients to take part, access to a wider patient pool and higher rates of patient engagement and retention.
Attendees will be able to explore and learn how the industry is coping with changes during this unprecedented time. This one-day online event will deliver a full agenda with cutting-edge content allowing industry experts to learn about how to adapt to direct-to-patient and virtual trials in a COVID and post- COVID world.
Attendees can stream live and pre-recorded presentations from top tier speakers on topics including the importance of direct-to-patient, data management in virtual clinical trials, and leveraging technology and data to create patient-centric medical device clinical trials. Connecting with other industry leaders will be possible via the platform’s live chat and video chat features– equipping attendees with the ability to reach their peers and colleagues globally.
A preview of the key sessions: